Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2020Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q2 $ vs. 2020Q2
Retrophin, Inc. NOTE 2.500% 9/1 45,000,000 $390,119,000 5.70% No Change +$40,140,000
BridgeBio Pharma, Inc. 6,706,268 $251,619,000 3.67% No Change +$32,928,000
MyoKardia, Inc. 1,395,017 $190,183,000 2.78% No Change +$55,396,000
COLLEGIUM PHARMACEUTICAL, INC NOTE 2.625% 2/1 17,500,000 $163,765,000 2.39% No Change +$6,538,000
VBI Vaccines Inc/BC 55,042,465 $157,421,000 2.30% No Change -$13,210,000
NEVRO CORP NOTE 2.750% 4/0 9,000,000 $141,822,000 2.07% No Change +$20,322,000
MeiraGTx Holdings plc 6,433,277 $85,176,000 1.24% No Change +$4,632,000
Forma Therapeutics Holdings, Inc., 1,250,000 $62,300,000 0.91% No Change +$4,187,000
Kadmon Holdings, Inc. 15,711,334 $61,588,000 0.90% No Change -$18,854,000
Retrophin, Inc. 3,240,112 $59,812,000 0.87% No Change +$30,941,000
Crinetics Pharmaceuticals, Inc. 3,659,381 $57,342,000 0.84% No Change -$1,829,000
ROCKET PHARMACEUTICALS, INC. 2,189,010 $50,041,000 0.73% No Change +$4,225,000
AGILE THERAPEUTICS INC 15,919,925 $48,397,000 0.71% No Change +$4,140,000
COLLEGIUM PHARMACEUTICAL, INC 2,058,068 $42,849,000 0.63% No Change +$6,833,000
Vaxcyte, Inc. 850,000 $41,973,000 0.61% No Change +$15,104,000
ADMA BIOLOGICS, INC. 16,584,802 $39,638,000 0.58% No Change -$8,955,000
Lyra Therapeutics, Inc. 3,222,561 $36,028,000 0.53% No Change -$515,000
Avidity Biosciences, Inc. 1,235,818 $34,788,000 0.51% No Change +$3,175,000
Eidos Therapeutics, Inc. 686,922 $34,710,000 0.51% No Change +$4,595,000
Zentalis Pharmaceuticals, Inc. 1,050,003 $34,325,000 0.50% No Change -$11,458,000
Turning Point Therapeutics, Inc. 329,890 $28,819,000 0.42% No Change +$7,511,000
Molecular Templates, Inc. 2,474,133 $27,018,000 0.39% No Change -$7,100,000
Fusion Pharmaceuticals Inc. 2,235,983 $26,877,000 0.39% No Change -$9,078,000
Verrica Pharmaceuticals Inc. 3,410,412 $26,397,000 0.39% No Change -$11,152,000
GERON CORP 13,461,538 $23,423,000 0.34% No Change -$5,923,000